Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/TEL1 stock hub

FRA/TEL1 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/TEL1is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.2B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/TEL1FRA/TEL1

—

Loading chart…

In the news

Latest news · FRA/TEL1

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E54.7

P25 n/aP50 n/aP75 n/a

ROE3.1

P25 n/aP50 n/aP75 n/a

ROIC5.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/TEL1 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

199

Groups with data

Currency

CNY

Showing 199 of 199 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Bermuda
Country code	DE
Employees	2,843
Employees Change	176%
Employees Change Percent	6.6
Enterprise value	EUR 961.1M
Exchange	Frankfurt Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 1.2B
Price	EUR 0.13
Price currency	EUR
Rev Per Employee	112,132.19x
Sic	2834
Symbol	fra/TEL1
Website	https://www.sihuanpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.83%
EV Earnings	43.92x
EV/EBIT	16.3x
EV/EBITDA	11.75x
EV/FCF	-96.36x
EV/Sales	3.04x
FCF yield	-0.83%
P/B ratio	1.42x
P/E ratio	54.71x
P/S ratio	3.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.21%
EBITDA Margin	24.55%
Gross margin	68.83%
Gross Profit	EUR 219.4M
Gross Profit Growth	29.59%
Gross Profit Growth Q	64.97%
Gross Profit Growth3 Y	15.93%
Gross Profit Growth5 Y	5.79%
Net Income	EUR 21.9M
Pretax Margin	15.93%
Profit Margin	6.86%
Profit Per Employee	EUR 7,697
ROA	2.69
Roa5y	0.06
ROCE	6
ROE	3.13
Roe5y	-7.97
ROIC	5.44
Roic5y	-5.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	2.28%
Cagr15y	2.43%
Cagr1y	66.84%
Cagr3y	18.03%
Cagr5y	-9.49%
Div CAGR10	-4.74%
Div CAGR3	-61.29%
Div CAGR5	-42.32%
FCF Growth Q	-81.39%
OCF Growth Q	-70.08%
Revenue Growth	37.71x
Revenue Growth Q	54.7x
Revenue Growth3 Y	14.27x
Revenue Growth5 Y	5.78x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.24
Assets	EUR 1.4B
Cash	EUR 484.3M
Current Assets	EUR 829.5M
Current Liabilities	EUR 460.1M
Debt	EUR 118.3M
Debt EBITDA	EUR 1.46
Debt Equity	EUR 0.14
Debt FCF	EUR -11.86
Equity	EUR 840.2M
Interest Coverage	2.36
Liabilities	EUR 576.2M
Long Term Assets	EUR 586.9M
Long Term Liabilities	EUR 116.1M
Net Cash	EUR 366M
Net Cash By Market Cap	EUR 30.57
Net Cash Growth	6.05%
Net Debt EBITDA	EUR -4.68
Net Debt Equity	EUR -0.44
Tangible Book Value	EUR 659M
Tangible Book Value Per Share	EUR 0.07

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.8
Inventory Turnover	1.58
Net Working Capital	EUR -94.7M
Quick ratio	1.47
Working Capital	EUR 360.8M
Working Capital Turnover	EUR 0.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.5%
Dividend Growth	-50.41%
Dividend Growth Years	0%
Dividend per share	EUR 0
Dividend Years	15
Dividend Yield	0.92%
Ex Div Date	2025-09-26
Last Dividend	EUR 0
Payout Frequency	Annual
Payout Ratio	50.58%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	25.28%
1Y total return	66.78%
200-day SMA	0.16
3Y total return	64.45%
50-day SMA	0.15
50-day SMA vs 200-day SMA	50under200
5Y total return	-39.25%
All Time High	0.8
All Time High Change	-83.75%
All Time High Date	2014-10-14
All Time Low	0.05
All Time Low Change	142.99%
All Time Low Date	2024-08-05
ATR	0
Ch YTD	-0.76
High	0.13
High52	0.21
High52 Date	2025-10-06
High52ch	-37.5%
Low	0.13
Low52	0.07
Low52 Date	2025-05-15
Low52ch	87.05%
Ma50ch	-12.69%
Price vs 200-day SMA	-16.88%
RSI	31.34
RSI Monthly	52.56
RSI Weekly	40.02
Sharpe ratio	1.11x
Sortino ratio	2
Total Return	2.43%
Tr YTD	-0.76
Tr15y	43.38%
Tr1m	-15.03%
Tr1w	-4.41%
Tr3m	-25.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 58M
Operating margin	18.21

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,709,675,502%
Net Borrowing	-938,633.4
Shares Insiders	7.83%
Shares Institutions	6.18%
Shares Qo Q	-1.68%
Shares Yo Y	-1.5%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -11.1M
Average Volume	0x
Bv Per Share	0.08
CAPEX	EUR -7.1M
Ch10y	-31.94
Ch15y	-32.29
Ch1m	-15.03
Ch1w	-4.41
Ch1y	65.61
Ch3m	-25.71
Ch3y	49.43
Ch5y	-53.57
Ch6m	-15.58
Change	-0.76%
Change From Open	0
Close	0.13
Days Gap	-0.76
Depreciation Amortization	20,684,098.4
Earnings Date	2026-03-31
EBIT	EUR 58M
EBITDA	EUR 78.2M
EPS	EUR 0
F Score	6
FCF	EUR -10M
FCF EV Yield	-1.04x
Financing CF	43,612,973
Fiscal Year End	December
Founded	2,001
Goodwill	231,042.5
Graham Number	0.06984
Graham Upside	-46.28
Income Tax	EUR 28.2M
Investing CF	-36,101,783
Is Primary Listing	0
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Last Split Date	2014-06-05
Last Split Type	Forward
Ma150	0.15
Ma150ch	-15.97%
Ma20	0.14
Ma20ch	-8.19%
Net CF	4,642,194
Open	0.13
Payment Date	2025-10-10
Ppne	307,915,266.1
Price Date	2026-05-08
Price EBITDA	EUR 15.3
Ptbv Ratio	1.82
Relative Volume	2,000x
Revenue	318,791,808x
SBC By Revenue	0.35x
Share Based Comp	1,099,816
Tax By Revenue	8.85x
Tax Rate	55.56%
Tr6m	-15.58%
Z Score	1.95

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/TEL1 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.9%

$0.00 annual per share

Payout ratio

+50.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-42.3%

0 consecutive years of growth

Total shareholder yield

+2.4%

Next ex-dividend date: 2025-09-26

Performance

FRA/TEL1 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/TEL1?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.2%

Share of float held by funds and institutions

Insider ownership

+7.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.5%

Negative means the company is buying back shares.

Technical

FRA/TEL1 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

31.3

Neutral momentum band

Price vs 200-day MA

-16.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.11

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/TEL1

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/TEL1 stock rating?

fra/TEL1 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/TEL1 analysis?

The full report lives at /stocks/fra/TEL1/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/TEL1?

The latest report frames fra/TEL1 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/TEL1 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.